Semaglutide and tirzepatide: Oral cavity effects of weight-loss therapies
EXCLI Journal · 09.01.2026 · 25 · 167-169
DOI: 10.17179/excli2025-9065 ↗Kurz gefasst
Leserbrief in der Zeitschrift EXCLI Journal, online erschienen am 09.01.2026. Verfasst von Maria Eduarda Bernardo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Post-Graduation Program of Dentistry, Center for Education and Research on Dental Implants, Federal University of Santa Catarina, Florianópolis, Braz…. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Post-Graduation Program of Dentistry, Center for Education and Research on Dental Implants, Federal University of Santa Catarina, Florianópolis, Brazil.
- Department of Dentistry, Universidad Católica Santiago de Guayaquil (UCSG), Guayaquil, Ecuador.
- Applied Virology Laboratory, Federal University of Santa Catarina, Florianópolis, Brazil.
Zitieren
APA
Bernardo, M. E., Dallepiane, F. G., Escobar, M., Cruz, A. C. C., & Benfatti, C. A. M. (2026). Semaglutide and tirzepatide: Oral cavity effects of weight-loss therapies. EXCLI Journal, 25, 167-169. https://doi.org/10.17179/excli2025-9065
Vancouver
Bernardo ME, Dallepiane FG, Escobar M, Cruz ACC, Benfatti CAM. Semaglutide and tirzepatide: Oral cavity effects of weight-loss therapies. EXCLI Journal. 2026;25:167-169. doi:10.17179/excli2025-9065
BibTeX
@article{Bernardo2026,
author = {Bernardo, Maria Eduarda and Dallepiane, Felipe Gomes and Escobar, Mario and Cruz, Ariadne Cristiane Cabral and Benfatti, Cesar Augusto Magalhães},
title = {Semaglutide and tirzepatide: Oral cavity effects of weight-loss therapies},
journal = {EXCLI Journal},
year = {2026},
volume = {25},
pages = {167--169},
doi = {10.17179/excli2025-9065}
}
EUVIMED